NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Pentagon’s Generative AI Push is ‘Game-Changing,’ Official Says
Federal AI leaders say the last six months have redefined what’s possible, and the next six could move even faster.
3m read -
Officials Say HTI-5 Proposal Reduces Complexity for Health IT Developers
Health IT officials say HHS’ HTI-5 proposed rule could cut administrative burden while laying groundwork for AI-based data exchange.
3m read -
Building Resilient AI Infrastructure
Officials from the Transportation Department, Government Accountability Office and CDW will discuss how agencies are navigating the transition from experimental AI to scalable, production-grade systems that deliver tangible ROI without requiring a "rip and replace" of existing legacy assets.
22m watch -
What’s Coming in Federal IT in 2026
Agency leaders are operationalizing AI and modernizing legacy software to meet the demands of a changing government landscape.
6m listen
